Akorn, Inc.
(Other OTC/NBB : AKRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 1.87%54.030.9%$2607.92m
JNJJohnson & Johnson 1.09%158.800.7%$1292.28m
MRKMerck & Co., Inc. -0.99%73.160.7%$1149.11m
BMYBristol-Myers Squibb Co. 1.15%56.051.0%$753.80m
LLYEli Lilly & Co. -1.66%243.771.1%$723.59m
ABBVAbbVie, Inc. 1.03%118.081.9%$588.02m
AZNAstraZeneca Plc -1.22%54.121.0%$289.70m
NVSNovartis AG -0.21%79.780.2%$176.19m
GSKGlaxoSmithKline Plc -0.75%41.160.2%$164.80m
DRNADicerna Pharmaceuticals, Inc. 0.08%38.150.3%$144.77m
VTRSViatris, Inc. -0.74%12.110.0%$140.33m
RPRXRoyalty Pharma Plc -3.63%37.470.1%$110.66m
RGENRepligen Corp. -3.02%260.716.7%$107.13m
BFRIBiofrontera, Inc. -21.33%4.130.0%$103.03m
NVONovo Nordisk A/S 0.22%106.870.1%$92.22m

Company Profile

Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe.